“There's a huge inertia in the system,” says Alan Shaw, CEO of one such firm, Cranbury, New Jersey–based VaxInnate. That's because existing producers have invested large amounts of time and ...
“He's a lab rat, like me,” says Alan Shaw, a prominent member of the Merck development team for Gardasil and now CEO of VaxInnate, a Cranbury, New Jersey–based flu vaccine start-up company.
and VaxInnate. mRNA vaccine heavyweights Pfizer/BioNTech and Moderna, meanwhile, are working on novel shots for flu, although, they are initially focusing their efforts on multivalent seasonal ...